Siltuximab (CNTO 328): a promising option for human malignancies

Overview of attention for article published in Drug Design, Development and Therapy, July 2015

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (67th percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter: 1 X user

patent: 1 patent

Citations

dimensions_citation: 53 Dimensions

Readers on

mendeley: 50 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 1 X post from an account with 3,355 followers.

#SiltuximabCNTO328: a promising option for #HumanMalignancies: http://t.co/RIRHMIq1rS

Reply Repost Favourite